TechnologyNetwork-test
APP NOTE

Development of an AlphaLISA Protein-Protein Interaction Assay to Screen for Re-Purposed Drugs as Targeted Disruptors

smartmockups_kpo69niu
BMG Logo 2

smartmockups_kpo69niu

The threat of global pandemics emphasises the quick identification of the cause of an emerging disease and its route of infection. Once these characteristics are defined, drug repurposing offers to identify previously approved drugs that might be applicable and quickly approvable for the treatment of the new disease. 

Download this app note to discover an assay that can:

  • Screen targeted disruptors of the interaction between SARS-CoV-2 and the human ACE2 protein 
  • Reduce the frequency of false positives 
  • Identify drugs that can be re-purposed for the treatments of SARS-CoV-2
   

Technology Networks Limited

Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK

Email: privacy@technologynetworks.com

© 2021 Technology Networks. All rights reserved
 
TechnologyNetwork-test

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy